Carbapenem-Resistant and Extensively Drug-Resistant Gram-Negative Healthcare-Associated Infections in a Romanian Tertiary Infectious Diseases Hospital: Phenotypic Landscape, Stewardship Gaps and Outcomes (2024–2025)
6 affiliations
- 1Doctoral School, , E. Murgu Square, No. 2, 300041 Timișoara, Romania; (R.R.); (V.B.B.)
- 2Department III Functional Sciences, Discipline of Medical Informatics and Biostatistics, , 300041 Timișoara, Romania
- 3Department XIII, Discipline of Infectious Diseases, , E. Murgu Square, Nr. 2, 300041 Timișoara, Romania; (R.L.); (M.-I.Ș.)
- 4Research Center for Medical Communication, , 300041 Timișoara, Romania;
- 5Department I, Discipline of Anatomy and Embryology, Faculty of Medicine, , Eftimie Murgu Square 2, 300041 Timișoara, Romania;
- 6Department of Epidemiology, , Eftimie Murgu Square 2, 300041 Timișoara, Romania;
Abstract
Background/Objectives: Romania reports among the highest rates of carbapenem-resistant Gram-negative bacteria in the European Union, but patient-level data on healthcare-associated infections (HAIs) are scarce. We characterised carbapenem resistance, in-hospital outcomes, and carbapenem prescribing in a 24-month HAI cohort. Methods: This was a retrospective study of 315 patients with microbiologically confirmed HAI (2024–2025) at a tertiary infectious diseases hospital, contributing 243 Gram-negative isolates. Carbapenem resistance was determined by the hospital laboratory; extensively drug-resistant (XDR) status, defined as susceptibility to no more than two of the antimicrobial classes tested, was assigned under the hospital surveillance protocol. Risk-factor analysis was exploratory. Results: Of 243 Gram-negative isolates, 162 (66.7%) were carbapenem-resistant and 150 of these (92.6%) were designated XDR. Resistance reached 90.6% in Klebsiella pneumoniae and 83.0% in Acinetobacter baumannii, against 33.3% in Pseudomonas aeruginosa and 0% in Escherichia coli, and occurred at every infection site. No routinely recorded characteristic distinguished resistant from susceptible infection after adjustment (area under the curve 0.62). In-hospital death was associated with intensive care transfer (adjusted odds ratio 6.92, 95% confidence interval 3.33–14.38) but not with carbapenem resistance (1.14, 0.52–2.50). Of 92 carbapenem recipients, 54 (58.7%) had a carbapenem-resistant isolate, against which carbapenems are inactive, and 12 (13.0%) had a Gram-negative isolate that was neither carbapenem-resistant nor extended-spectrum β-lactamase-producing. Conclusions: At this centre, carbapenem resistance in Gram-negative HAI is endemic, could not be predicted from the routinely recorded characteristics examined, and exceeds European surveillance figures only among the Enterobacterales. No independent association with mortality was detected, although the susceptible comparison group was small. The XDR proportion was assigned under the hospital surveillance protocol and is not directly comparable with category-based estimates. Because antibiotic exposure was recorded without timing relative to culture sampling, these data support prospective audit of carbapenem prescribing rather than demonstrating missed de-escalation.
Related
- Carbapenem-resistant Acinetobacter baumannii infections in intensive care units: incidence, infection prevention and control, and antimicrobial stewardship practices in the cross-border region between Italy and France, 2019–2022
- Development and content validation of a risk-stratified nursing intervention programme for the prevention of healthcare-associated infections
- Prevalence, Etiology, and Clinical Outcomes of Healthcare-Associated Infections in a Tertiary Pediatric Hospital.
- Epidemiology, microbiological characteristics, and antimicrobial resistance of device-associated healthcare-associated infections in a neonatal intensive care unit: a six-year surveillance study
- Azithromycin in crisis: antimicrobial resistance, diagnostics gaps, and vaccine-linked stewardship for enteric infections in low- and middle-income countries
BibTeX
@article{roșca2026carbapenemresistant,
title = {{Carbapenem-Resistant and Extensively Drug-Resistant Gram-Negative Healthcare-Associated Infections in a Romanian Tertiary Infectious Diseases Hospital: Phenotypic Landscape, Stewardship Gaps and Outcomes (2024–2025)}},
author = {Răzvan Roșca and Călin Muntean and Mirela Frandeș and Ruxandra Laza and Daian-Ionel Popa and Victor Bogdan Buciu and Cătălin Prodan-Bărbulescu and Mădălina-Ianca Șuba and Sorina Maria Denisa Laitin},
journal = {Antibiotics (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/antibiotics15101003},
url = {https://europepmc.org/article/PMC/PMC13700804},
note = {CC BY},
}
RIS
TY - JOUR
TI - Carbapenem-Resistant and Extensively Drug-Resistant Gram-Negative Healthcare-Associated Infections in a Romanian Tertiary Infectious Diseases Hospital: Phenotypic Landscape, Stewardship Gaps and Outcomes (2024–2025)
AU - Răzvan Roșca
AU - Călin Muntean
AU - Mirela Frandeș
AU - Ruxandra Laza
AU - Daian-Ionel Popa
AU - Victor Bogdan Buciu
AU - Cătălin Prodan-Bărbulescu
AU - Mădălina-Ianca Șuba
AU - Sorina Maria Denisa Laitin
PY - 2026
DA - 2026/10/01
JO - Antibiotics (Basel, Switzerland)
DO - 10.3390/antibiotics15101003
UR - https://europepmc.org/article/PMC/PMC13700804
AB - Background/Objectives: Romania reports among the highest rates of carbapenem-resistant Gram-negative bacteria in the European Union, but patient-level data on healthcare-associated infections (HAIs) are scarce. We characterised carbapenem resistance, in-hospital outcomes, and carbapenem prescribing in a 24-month HAI cohort. Methods: This was a retrospective study of 315 patients with microbiologically confirmed HAI (2024–2025) at a tertiary infectious diseases hospital, contributing 243 Gram-negative isolates. Carbapenem resistance was determined by the hospital laboratory; extensively drug-resistant (XDR) status, defined as susceptibility to no more than two of the antimicrobial classes tested, was assigned under the hospital surveillance protocol. Risk-factor analysis was exploratory. Results: Of 243 Gram-negative isolates, 162 (66.7%) were carbapenem-resistant and 150 of these (92.6%) were designated XDR. Resistance reached 90.6% in Klebsiella pneumoniae and 83.0% in Acinetobacter baumannii, against 33.3% in Pseudomonas aeruginosa and 0% in Escherichia coli, and occurred at every infection site. No routinely recorded characteristic distinguished resistant from susceptible infection after adjustment (area under the curve 0.62). In-hospital death was associated with intensive care transfer (adjusted odds ratio 6.92, 95% confidence interval 3.33–14.38) but not with carbapenem resistance (1.14, 0.52–2.50). Of 92 carbapenem recipients, 54 (58.7%) had a carbapenem-resistant isolate, against which carbapenems are inactive, and 12 (13.0%) had a Gram-negative isolate that was neither carbapenem-resistant nor extended-spectrum β-lactamase-producing. Conclusions: At this centre, carbapenem resistance in Gram-negative HAI is endemic, could not be predicted from the routinely recorded characteristics examined, and exceeds European surveillance figures only among the Enterobacterales. No independent association with mortality was detected, although the susceptible comparison group was small. The XDR proportion was assigned under the hospital surveillance protocol and is not directly comparable with category-based estimates. Because antibiotic exposure was recorded without timing relative to culture sampling, these data support prospective audit of carbapenem prescribing rather than demonstrating missed de-escalation.
SN - 2079-6382
ER -